Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Other Operating Expenses (2017 - 2024)

iBio (IBIO) has disclosed Other Operating Expenses for 9 consecutive years, with $1.0 million as the latest value for Q1 2024.

  • Quarterly Other Operating Expenses changed N/A to $1.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at $1.0 million for FY2024, N/A changed from the prior year.
  • Other Operating Expenses for Q1 2024 was $1.0 million at iBio, down from $5.7 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $5.7 million in Q4 2022, with the low at -$193000.0 in Q2 2021.
  • Average Other Operating Expenses over 4 years is $530500.0, with a median of -$182500.0 recorded in 2020.
  • The sharpest move saw Other Operating Expenses dropped 8.19% in 2020, then skyrocketed 9385.25% in 2022.
  • Over 4 years, Other Operating Expenses stood at -$177000.0 in 2020, then skyrocketed by 65.54% to -$61000.0 in 2021, then surged by 9385.25% to $5.7 million in 2022, then tumbled by 82.34% to $1.0 million in 2024.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $1.0 million, $5.7 million, and -$61000.0 for Q1 2024, Q4 2022, and Q4 2021 respectively.